Talk:Dehydron/Archive 1

Archive 1

delete nomination

This article and the similarly flawed Wrapping technology seem to exist to promote Ariel Fernandez. They do not meet criteria of notability, they are unreadably technical, and are promotional. Jytdog (talk) 23:26, 6 February 2014 (UTC)

I undid the additions by User:Haydee Belinky and reported this user on WP:AIV for spamming. --Leyo 23:34, 6 February 2014 (UTC)

OK I will nominate this article for deletion the regular way. Everything I said above remains true. Jytdog (talk) 23:41, 6 February 2014 (UTC)

I have removed any promotional content from the article Dehydron.

Haydee Belinky. — Preceding unsigned comment added by Haydee Belinky (talk • contribs) 00:54, 7 February 2014 (UTC)

This page should not be speedy deleted because...

This page should not be speedily deleted because the dehydron constitutes a significant invention in drug discovery. The dehydron has been quite universally accepted as evidenced by the number of reviews in major venues such as Nature, BBC News, Scientific American, The UK Royal Society of Chemistry, etc. Here are the links:

Nature BBC News Scientific American Royal Society of Chemistry

Furthermore, the dehydron-based engineering as applied to imatinib redesign has been further reviewed by prominent Harvard Oncologist George Demetri: Review by George Demetri

Here is the coverage of the discovery of the dehydron at the University of Chicago (press release)

University of Chicago Press release

If the article as it stands appears to be somewhat promotional, I offer to edit as needed to make it look completely objective. Thanks for your attention.

Haydee Belinky Haydee Belinky (talk) 23:54, 6 February 2014 (UTC)

... (your reason here) --Haydee Belinky (talk) 23:54, 6 February 2014 (UTC)

This page should not be speedy deleted because...

This page should not be speedily deleted because the dehydron constitutes a significant invention in drug discovery. The dehydron has been quite universally accepted as evidenced by the number of reviews in major venues such as Nature, BBC News, Scientific American, The UK Royal Society of Chemistry, etc. Here are the links:

Nature BBC News Scientific American Royal Society of Chemistry

Furthermore, the dehydron-based engineering as applied to imatinib redesign has been further reviewed by prominent Harvard Oncologist George Demetri: Review by George Demetri

Here is the coverage of the discovery of the dehydron at the University of Chicago (press release)

University of Chicago Press release

If the article as it stands appears to be somewhat promotional, I offer to edit as needed to make it look completely objective. Thanks for your attention.

Haydee Belinky Haydee Belinky (talk) 23:55, 6 February 2014 (UTC)

I have now documented the statements with sources including reviews in Nature, Scientific American, Royal Society, Chemical Society Reviews and Project Syndicate. I have also removed promotional content. Further improvements welcome!--Haydee Belinky (talk)

Semi-protected edit request on 28 March 2014

Please update the PyMOL Wiki link to http://wiki.pymol.org/index.php/Dehydron we've moved the site to improve user experience and the old link will soon become a redirect 38.104.105.10 (talk) 21:29, 28 March 2014 (UTC)

Done. Anon126 (talk - contribs) 01:52, 29 March 2014 (UTC)